ALLUCENT - Trademark Details
Status: 748 - Statement Of Use - To Examiner
Serial Number
97978222
Word Mark
ALLUCENT
Status
748 - Statement Of Use - To Examiner
Status Date
2024-05-21
Filing Date
2022-04-20
Mark Drawing
3 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Design Searches
260521, 261321, 270301 - Triangles that are completely or partially shaded. Quadrilaterals that are completely or partially shaded. Geometric figures forming letters or numerals, including punctuation.
Attorney Name
Law Office Assigned Location Code
L30
Employee Name
IN, SUNG HYUN
Statements
Indication of Colors claimed
The color(s) dark blue, orange and gold is/are claimed as a feature of the mark.
Description of Mark
The mark consists of the word ALLUCENT appearing dark blue with the inside space of the capital letter "A" filled in with an orange triangle in the top half of the "A" that extends between the two outside lines of the "A" and a gold trapezoid in the bottom half of the "A" and the remaining letters appearing in dark blue lowercase.
Goods and Services
Data management, namely, abstraction services in the nature of extracting and summarizing information from clinical trial records and collection of medical data from clinical tests and records for business purposes; Market research and business marketing consulting services in the pharmaceutical, biotechnology, medical device, and diagnostics industries; Data management, namely, the management for others of databases of patient health data
Goods and Services
Training and development in the field of conducting clinical trials, namely, conducting tutorials, seminars and workshops in the field of clinical trials; training in the field of computer software support, namely, conducting tutorials, seminars and workshops in the field of software support
Goods and Services
Cloud computing featuring software that allows users to collect, review, analyze and report on clinical research; technical support services, namely, installation and remote administration of software, and troubleshooting of software problems and hosted software applications, all for use in connection with medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; cloud computing featuring software for providing telehealth, telemedicine, remote care and virtual health care services to patients; cloud computing featuring software that allows users to collect, track, retrieve, validate, summarize, statistically analyze and present data used in the areas of medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; Cloud computing featuring software to aggregate, integrate, transfer and manage data generated from home health and remote monitoring devices and applications and health-related smart-phone applications; Cloud computing featuring software that provides integrated workflows, analytics, visualizations, and reporting features to deliver, process, analyze, elevate, and display patient-generated health data; Cloud computing featuring software that integrates remotely collected health data into databases, systems, platforms, applications, and software that inform clinical research, remote monitoring, and care management; technical consulting services, namely, evaluating the safety of pharmaceutical, medical, cosmetic and consumer devices and products in clinical development or in commercial production; Consulting services for others in the fields of design, planning, implementation and project management of clinical trials; Scientific analysis of statistical and qualitative data relating to clinical trials for pharmaceuticals, biotechnology, medical devices and diagnostics for scientific research and for the development of pharmaceutical, biotechnology, medical device and diagnostic products and methods of use of such devices and products
Goods and Services
Development of regulatory compliance strategies in the field of medical research, namely, regulatory compliance consulting in the field of drug, biologic, cosmetic and medical device development
Classification Information
International Class
035 - Advertising; business management; business administration; office functions. - Advertising; business management; business administration; office functions.
US Class Codes
100, 101, 102
Class Status Code
6 - Active
Class Status Date
2022-04-26
Primary Code
035
First Use Anywhere Date
2022-05-01
First Use In Commerce Date
2022-05-01
International Class
041 - Education; providing of training; entertainment; sporting and cultural activities. - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes
100, 101, 107
Class Status Code
6 - Active
Class Status Date
2022-04-26
Primary Code
041
First Use Anywhere Date
2022-05-01
First Use In Commerce Date
2022-05-01
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2022-04-26
Primary Code
042
First Use Anywhere Date
2022-05-01
First Use In Commerce Date
2022-05-01
International Class
045 - Personal and social services rendered by others to meet the needs of individuals; security services for the protection of property and individuals. - Personal and social services rendered by others to meet the needs of individuals; security services for the protection of property and individuals.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2022-04-26
Primary Code
045
First Use Anywhere Date
2022-05-01
First Use In Commerce Date
2022-05-01
Current Trademark Owners
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Laura M. Franco Winston & Strawn LLP
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2022-04-23 | NEW APPLICATION ENTERED |
| 2022-04-26 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 2022-04-27 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 2022-11-21 | LETTER OF PROTEST EVIDENCE FORWARDED |
| 2022-12-28 | ASSIGNED TO EXAMINER |
| 2023-01-04 | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN |
| 2023-01-06 | NON-FINAL ACTION WRITTEN |
| 2023-01-06 | NON-FINAL ACTION E-MAILED |
| 2023-01-06 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2023-04-06 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2023-04-06 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2023-04-06 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2023-05-16 | FINAL REFUSAL WRITTEN |
| 2023-05-16 | FINAL REFUSAL E-MAILED |
| 2023-05-16 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 2023-06-21 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 2023-06-21 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2023-06-22 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2023-07-03 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2023-07-13 | WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST |
| 2023-07-13 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| 2023-07-29 | EXAMINERS AMENDMENT -WRITTEN |
| 2023-07-29 | EXAMINERS AMENDMENT E-MAILED |
| 2023-07-29 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2023-07-29 | EXAMINER'S AMENDMENT ENTERED |
| 2023-07-29 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2023-08-16 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2023-09-05 | PUBLISHED FOR OPPOSITION |
| 2023-09-05 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2023-10-31 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2024-03-26 | SOU TEAS EXTENSION RECEIVED |
| 2024-03-26 | SOU EXTENSION 1 FILED |
| 2024-03-26 | SOU EXTENSION 1 GRANTED |
| 2024-03-27 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2024-04-04 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2024-04-04 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2024-04-04 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2024-04-04 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| 2024-04-11 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2024-04-11 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2024-04-11 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2024-04-11 | TEAS STATEMENT OF USE RECEIVED |
| 2024-04-11 | TEAS REQUEST TO DIVIDE RECEIVED |
| 2024-05-02 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2024-04-11 | DIVISIONAL REQUEST RECEIVED |
| 2024-05-21 | DIVISIONAL PROCESSING COMPLETE |
| 2024-04-11 | USE AMENDMENT FILED |
| 2024-05-21 | STATEMENT OF USE PROCESSING COMPLETE |
